Safety switch optimization enhances antibody-mediated elimination of CAR T cells.

By contrast, cetuximab-treated mice exhibited B cell recovery within 2 weeks of drug administration in the EGFRopt cohort, which was a week earlier than the EGFRt cohort but did not reach statistical significance ( Figure 4C ).

also in 111,027 other papers